Veterinary Medicines

AVINEW NEO EFFERVESCENT TABLET FOR CHICKENS AND TURKEYS

Authorised
  • Newcastle disease virus, strain VG/GA, Live
Download as PDF

Product identification

Medicine name:
AVINEW NEO EFFERVESCENT TABLET FOR CHICKENS AND TURKEYS
Avinew NEO bruistablet voor kippen en kalkoenen
Active substance:
  • Newcastle disease virus, strain VG/GA, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
  • Turkey
Route of administration:
  • Ocular use
  • Oral use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain VG/GA, Live
    5.50
    log10 tissue culture infective dose 50
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Effervescent tablet
Withdrawal period by route of administration:
  • Ocular use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oculonasal use
    • Turkey
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Box of 10 blisters of 10 tablets of 2,000 doses
  • Box of 1 blister of 10 tablets of 1,000 doses
  • Box of 1 blister of 10 tablets of 2,000 doses
  • Box of 10 blisters of 10 tablets of 1,000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Netherlands B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 117276
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0296/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Greece
  • Ireland
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/08/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."